Loading data for ARMP — first visit, this takes a few seconds.
Armata Pharmaceuticals, Inc. (ARMP)
NYSE American: ARMP
· 实时价格 · USD
5.84
+0.32 (5.80%)
收盘价： Sep 10, 2026, 8:00 PM
5.23
+0.58%
盘后: 4:01 PM
股价、关键数字和最新消息，都在这一页。
Armata Pharmaceuticals, Inc.（ARMP）股价、分析与数据
暂无数据
| 买价 | 5.7 |
| 市值 | 194M |
| 营收（TTM） | 5.54M |
| 净利润（TTM） | -192M |
| 1.35 | |
| -5.29 | |
| n/a | |
| -3.33 | |
| 市净率（TTM） | -0.84 |
| 市销率（TTM） | 35.08 |
| 财报日期 | Nov 11, 2026 |
| 卖价 | 5.84 |
| 成交量 | 48,029 |
| 20日均量 | 154,653 |
| 开盘价 | 5.49 |
| 前收盘价 | 5.52 |
| 日内区间 | 5.48 - 5.84 |
| 52周区间 | 2.79 - 16.34 |
| 分析师 | n/a |
| 目标价 | n/a |
| 分红 | n/a |
| 除息日 | n/a |
关于 ARMP
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa . The company is based in Los Ange...
公司完整简介财报意外
Armata Pharmaceuticals 已于 Aug 12, 2026 发布季度财报：
- 营收为 $0 低于预期 $0, ， NaN% 同比增长.
- 每股收益为 1.2 超出预期 1.64, ， 513.79% 同比增长.
第 1 页，共 2 页